Concepedia

Author

Cyrill Wehling

Heidelberg University

Also Known As

C Wehling, C. Wehling, Christina Wehling, Cyrill Wehling

23

Publications

418

Citations

10

H-Index

20

Concepts

All Affiliations

Heidelberg UniversityUniversity Hospital HeidelbergUniversity Medical Center FreiburgUniversity Hospital BonnHopp Children's Cancer Center Heidelberg
CW

About

Cyrill Wehling is an author at Heidelberg University specializing in immunology, allergy, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

157

2

Allergy

2

2

157

3

Immunology

2

2

157

4

Allergy Medicine

1

1

52

5

Nephrology

1

1

105

Cyrill Wehling

×

9

Publications

316

Citations

9

H-Index

YearCitations

Monitoring of complement activation biomarkers and eculizumab in complement-mediated renal disorders

Cyrill Wehling, Oliver Amon, Martin Bommer,

Clinical & Experimental Immunology

2016

105

Controlling the anaphylatoxin C5a in diseases requires a specifically targeted inhibition

Niels C. Riedemann, Maria Habel, Jana Ziereisen,

Clinical Immunology

2017

52

Ustekinumab: “Real-world” outcomes and potential predictors of nonresponse in treatment-refractory Crohn’s disease

Péter Hoffmann, Johannes Krisam, Cyrill Wehling,

World Journal of Gastroenterology

2019

47

Performance of tacrolimus in hospitalized patients with steroid-refractory acute severe ulcerative colitis

Péter Hoffmann, Cyrill Wehling, Johannes Krisam,

World Journal of Gastroenterology

2019

29

Systemic complement activation and complement gene analysis in enterohaemorrhagic<i>Escherichia coli</i>-associated paediatric haemolytic uraemic syndrome

Thurid Ahlenstiel-Grunow, Svenja Hachmeister, Franz Bange,

Nephrology Dialysis Transplantation

2016

25

Durvalumab Plus Gemcitabine and Cisplatin in Patients with Advanced Biliary Tract Cancer: An Exploratory Analysis of Real-World Data

Alexander Olkus, Aurelie Tomczak, Anne Berger,

Targeted Oncology

2024

20

A complicated case of atypical hemolytic uremic syndrome with frequent relapses under eculizumab

Gesa Schalk, Michael Kirschfink, Cyrill Wehling,

Pediatric Nephrology

2015

17

Treatment stage migration and treatment sequences in patients with hepatocellular carcinoma: drawbacks and opportunities

Cyrill Wehling, Michael T. Dill, Alexander Olkus,

Journal of Cancer Research and Clinical Oncology

2021

11

Routine Liver Elastography Could Predict Actuarial Survival after Liver Transplantation

Jan Pfeiffenberger, Philip Houben, Cyrill Wehling,

Journal of Gastrointestinal and Liver Diseases

2019

10

Page 1